Spots Global Cancer Trial Database for diagnostic laboratory biomarker analysis

Every month we try and update this database with for diagnostic laboratory biomarker analysis cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Development of a Model to Predict Progression-Free Survival After Erlotinib in Patients With Non-Small Cell Lung Cancer	NCT00897533	Lung Cancer	gene mapping polymorphism an... diagnostic labo... immunohistochem...	- 120 Years	Eastern Cooperative Oncology Group
ABT-888 and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors	NCT01154426	Adult Solid Neo... BRCA1 Mutation ... BRCA2 Mutation ...	Diagnostic Labo... Gemcitabine Hyd... Pharmacological... Veliparib	18 Years -	National Cancer Institute (NCI)
Everolimus in Combination With Imatinib Mesylate in Treating Patients With Locally Advanced, Locally Recurrent, or Metastatic Soft Tissue Sarcoma	NCT01281865	Adult Synovial ... Recurrent Adult... Stage III Adult... Stage IV Adult ...	diagnostic labo... everolimus imatinib mesyla...	18 Years -	National Cancer Institute (NCI)
Development of a Model to Predict Progression-Free Survival After Erlotinib in Patients With Non-Small Cell Lung Cancer	NCT00897533	Lung Cancer	gene mapping polymorphism an... diagnostic labo... immunohistochem...	- 120 Years	Eastern Cooperative Oncology Group
Lenalidomide in Treating Patients With High-Risk Chronic Lymphocytic Leukemia	NCT01271283	Chronic Lymphoc... Stage III Chron... Stage IV Chroni...	Diagnostic Labo... Lenalidomide	18 Years -	National Cancer Institute (NCI)
Studying Changes in Breast Density in Patients With Early-Stage Breast Cancer Treated With Metformin Hydrochloride or Placebo on CAN-NCIC-MA.32	NCT01666171	Breast Cancer	metformin hydro... clinical observ... diagnostic labo... imaging biomark... medical chart r... digital mammogr...	18 Years - 74 Years	National Cancer Institute (NCI)
SARS-CoV-2 Donor-Recipient Immunity Transfer	NCT04666025	Accelerated Pha... Acute Lymphobla... Acute Myeloid L... Chronic Lymphoc... Chronic Phase C... COVID-19 Infect... Hematopoietic a... Hodgkin Lymphom... Lymphoblastic L... Myelodysplastic... Myelofibrosis Myeloproliferat... Non-Hodgkin Lym...	Biospecimen Col... Diagnostic Labo... Electronic Heal... Questionnaire A...	18 Years -	City of Hope Medical Center
Changes in DNA After Radiation Therapy in Patients With Prostate Cancer	NCT00899912	Prostate Cancer	microarray anal... diagnostic labo...	18 Years -	Radiation Therapy Oncology Group
Everolimus in Combination With Imatinib Mesylate in Treating Patients With Locally Advanced, Locally Recurrent, or Metastatic Soft Tissue Sarcoma	NCT01281865	Adult Synovial ... Recurrent Adult... Stage III Adult... Stage IV Adult ...	diagnostic labo... everolimus imatinib mesyla...	18 Years -	National Cancer Institute (NCI)
Studying Tumor Tissue Samples From Patients With Melanoma Who Have Undergone Sentinel Lymph Node Biopsy	NCT00897481	Melanoma (Skin)	gene expression... mutation analys... diagnostic labo... immunohistochem... sentinel lymph ...	-	National Cancer Institute (NCI)
Lymphatic Mapping, Sentinel Lymph Node Analysis, and Blood Tests in Detecting and Predicting Early Micrometastases in Patients With Colorectal Cancer	NCT00625625	Colorectal Canc...	isosulfan blue polymerase chai... diagnostic labo... immunohistochem... diagnostic lymp... therapeutic con... therapeutic lym...	18 Years -	National Cancer Institute (NCI)
Predictive Biomarkers for Pneumonitis After Chemoradiotherapy and Immunotherapy in Patients With Non-small Cell Lung Cancer	NCT04913311	Lung Non-Small ...	Biospecimen Col... Bronchoscopy wi... Chemoradiothera... Computed Tomogr... Diagnostic Labo... Immune Checkpoi... Nasal Wash and ... Quality-of-Life... Questionnaire A... Spirometry	-	M.D. Anderson Cancer Center
Studying Tumor Tissue Samples From Patients With Melanoma Who Have Undergone Sentinel Lymph Node Biopsy	NCT00897481	Melanoma (Skin)	gene expression... mutation analys... diagnostic labo... immunohistochem... sentinel lymph ...	-	National Cancer Institute (NCI)
TLR8 Agonist VTX-2337 and Pegylated Liposomal Doxorubicin Hydrochloride or Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer	NCT01294293	Malignant Ovari... Ovarian Brenner... Ovarian Clear C... Ovarian Endomet... Ovarian Mucinou... Ovarian Serous ... Recurrent Fallo... Recurrent Ovari... Recurrent Prima... Undifferentiate...	TLR8 Agonist VT... Diagnostic Labo... Pharmacological... Pegylated Lipos... Paclitaxel	18 Years -	GOG Foundation
7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)	NCT00031681	Advanced Adult ... Carcinoma of th... Estrogen Recept... Extensive Stage... Gastrointestina... HER2-negative B... Metastatic Gast... Ovarian Sarcoma Ovarian Stromal... Progesterone Re... Recurrent Adeno... Recurrent Adult... Recurrent Anal ... Recurrent Basal... Recurrent Borde... Recurrent Breas... Recurrent Cervi... Recurrent Colon... Recurrent Endom... Recurrent Esoph... Recurrent Esthe... Recurrent Extra... Recurrent Gallb... Recurrent Gastr... Recurrent Gastr... Recurrent Inver... Recurrent Lymph... Recurrent Lymph... Recurrent Metas... Recurrent Midli... Recurrent Mucoe... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Prost... Recurrent Recta... Recurrent Saliv... Recurrent Small... Recurrent Small... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Verru... Recurrent Verru... Small Intestine... Small Intestine... Small Intestine... Stage IV Adenoi... Stage IV Anal C... Stage IV Basal ... Stage IV Border... Stage IV Breast... Stage IV Colon ... Stage IV Endome... Stage IV Esopha... Stage IV Esthes... Stage IV Gastri... Stage IV Invert... Stage IV Lympho... Stage IV Lympho... Stage IV Midlin... Stage IV Mucoep... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Prosta... Stage IV Rectal... Stage IV Saliva... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Verruc... Stage IV Verruc... Stage IVA Cervi... Stage IVB Cervi... Triple-negative... Unresectable Ex... Unresectable Ga... Unspecified Adu... Untreated Metas...	7-hydroxystauro... irinotecan hydr... diagnostic labo...	18 Years -	National Cancer Institute (NCI)
Lapatinib in Treating Patients With Advanced or Metastatic Breast Cancer That Overexpresses HER2	NCT00544804	Breast Cancer Metastatic Canc...	lapatinib ditos... gene expression... diagnostic labo...	18 Years -	University of California, San Francisco
Study of Cerebrospinal Fluid Samples in Diagnosing Carcinomatous Meningitis in Patients With Cancer or Meningeal Syndrome	NCT00938756	Brain and Centr... Breast Cancer Metastatic Canc...	diagnostic labo... immunoenzyme te... magnetic resona...	18 Years -	National Cancer Institute (NCI)
Studying Tissue Samples From Women With Breast Cancer Who Were Treated on Clinical Trial NCCTG-N9831	NCT00898898	Breast Cancer	diagnostic labo...	18 Years -	Alliance for Clinical Trials in Oncology
Combination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes	NCT00454480	Leukemia Myelodysplastic...	alemtuzumab arsenic trioxid... azacitidine busulfan clofarabine cytarabine daunorubicin hy... fludarabine pho... gemtuzumab ozog... melphalan tipifarnib DNA methylation... cytogenetic ana... gene expression... mutation analys... diagnostic labo... immunologic tec... allogeneic hema... nonmyeloablativ...	-	National Cancer Institute (NCI)
Biomarkers in Tissue Samples From Patients Who Have Undergone Neck Dissection for Oral Cancer	NCT00899704	Head and Neck C...	microarray anal... allele-specific... diagnostic labo...	-	Alliance for Clinical Trials in Oncology
Prognostic Biomarkers in Tumor Tissue Samples From Young Patients With Neuroblastoma	NCT01358617	Disseminated Ne... Localized Resec... Localized Unres... Recurrent Neuro... Stage 4S Neurob...	diagnostic labo...	-	Children's Oncology Group
DNA Analysis of Tumor Tissue From Patients With Acute Myeloid Leukemia	NCT00897936	Leukemia	DNA methylation... comparative gen... fluorescence in... microarray anal... polymerase chai... diagnostic labo... immunologic tec...	18 Years - 120 Years	Eastern Cooperative Oncology Group
Viral Therapy in Treating Patients With Relapsed or Refractory Multiple Myeloma	NCT01533194	Light Chain Dep... Refractory Plas...	Diagnostic Labo... Wild-type Reovi...	18 Years -	National Cancer Institute (NCI)
Nivolumab for the Treatment of Patients With Metastatic Urothelial Cancer With ARID1A Mutation and Stratify Response Based on CXCL13 Expression	NCT04953104	Locally Advance... Locally Advance... Locally Advance... Locally Advance... Locally Advance... Metastatic Blad... Metastatic Rena... Metastatic Uret... Metastatic Uret... Metastatic Urot... Recurrent Bladd... Recurrent Renal... Recurrent Urete... Recurrent Ureth... Recurrent Uroth... Stage III Bladd... Stage III Renal... Stage III Urete... Stage III Ureth... Stage IIIA Blad... Stage IIIB Blad... Stage IV Bladde... Stage IV Renal ... Stage IV Ureter... Stage IV Urethr... Stage IVA Bladd... Stage IVB Bladd... Unresectable Bl... Unresectable Re... Unresectable Ur... Unresectable Ur... Unresectable Ur...	Diagnostic Labo... Nivolumab Relatlimab	18 Years -	M.D. Anderson Cancer Center
Dasatinib and Cyclosporine in Treating Patients With Chronic Myelogenous Leukemia Refractory or Intolerant to Imatinib Mesylate	NCT01426334	Accelerated Pha... Chronic Myeloge... Chronic Phase C... Relapsing Chron...	dasatinib diagnostic labo... pharmacological... cyclosporine	18 Years -	National Cancer Institute (NCI)
Lymphatic Mapping, Sentinel Lymph Node Analysis, and Blood Tests in Detecting and Predicting Early Micrometastases in Patients With Colorectal Cancer	NCT00625625	Colorectal Canc...	isosulfan blue polymerase chai... diagnostic labo... immunohistochem... diagnostic lymp... therapeutic con... therapeutic lym...	18 Years -	National Cancer Institute (NCI)
Genetic Testing in Predicting Biomarkers of Recurrence in Patients With Prostate Cancer Undergoing Surgery	NCT00977457	Prostate Cancer	DNA analysis DNA methylation... RNA analysis gene expression... polymerase chai... diagnostic labo... therapeutic con...	18 Years -	City of Hope Medical Center
CA 125 Levels in Treating Patients With Relapsed Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Who Are Receiving Tamoxifen	NCT00305838	Fallopian Tube ... Ovarian Cancer Primary Periton...	tamoxifen citra... diagnostic labo...	-	National Cancer Institute (NCI)
Nivolumab for the Treatment of Patients With Metastatic Urothelial Cancer With ARID1A Mutation and Stratify Response Based on CXCL13 Expression	NCT04953104	Locally Advance... Locally Advance... Locally Advance... Locally Advance... Locally Advance... Metastatic Blad... Metastatic Rena... Metastatic Uret... Metastatic Uret... Metastatic Urot... Recurrent Bladd... Recurrent Renal... Recurrent Urete... Recurrent Ureth... Recurrent Uroth... Stage III Bladd... Stage III Renal... Stage III Urete... Stage III Ureth... Stage IIIA Blad... Stage IIIB Blad... Stage IV Bladde... Stage IV Renal ... Stage IV Ureter... Stage IV Urethr... Stage IVA Bladd... Stage IVB Bladd... Unresectable Bl... Unresectable Re... Unresectable Ur... Unresectable Ur... Unresectable Ur...	Diagnostic Labo... Nivolumab Relatlimab	18 Years -	M.D. Anderson Cancer Center
Lymphatic Mapping, Sentinel Lymph Node Analysis, and Blood Tests in Detecting and Predicting Early Micrometastases in Patients With Colorectal Cancer	NCT00625625	Colorectal Canc...	isosulfan blue polymerase chai... diagnostic labo... immunohistochem... diagnostic lymp... therapeutic con... therapeutic lym...	18 Years -	National Cancer Institute (NCI)
Multidrug Resistance Genes in Patients With Acute Myeloid Leukemia	NCT00898456	Leukemia	gene expression... molecular genet... polymorphism an... protein express... diagnostic labo...	15 Years -	Alliance for Clinical Trials in Oncology
Lapatinib in Treating Patients With Advanced or Metastatic Breast Cancer That Overexpresses HER2	NCT00544804	Breast Cancer Metastatic Canc...	lapatinib ditos... gene expression... diagnostic labo...	18 Years -	University of California, San Francisco
Improving the Selection of Patients With Glioblastoma Multiforme for Treatment With Epidermal Growth Factor Receptor Inhibitor Therapies	NCT00897663	Brain and Centr...	gene expression... microarray anal... protein express... diagnostic labo... immunohistochem...	18 Years -	Alliance for Clinical Trials in Oncology
Biomarkers in Tissue Samples From Patients With High-Risk Wilms Tumor	NCT01118078	Clear Cell Sarc... Recurrent Wilms... Rhabdoid Tumor ... Stage I Wilms T... Stage II Wilms ... Stage III Wilms... Stage IV Wilms ... Stage V Wilms T...	DNA methylation... gene expression... microarray anal... reverse transcr... diagnostic labo...	- 16 Years	Children's Oncology Group
Bevacizumab and Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer	NCT00544011	Colorectal Canc...	bevacizumab capecitabine fluorouracil irinotecan hydr... diagnostic labo...	18 Years - 80 Years	National Cancer Institute (NCI)
7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)	NCT00031681	Advanced Adult ... Carcinoma of th... Estrogen Recept... Extensive Stage... Gastrointestina... HER2-negative B... Metastatic Gast... Ovarian Sarcoma Ovarian Stromal... Progesterone Re... Recurrent Adeno... Recurrent Adult... Recurrent Anal ... Recurrent Basal... Recurrent Borde... Recurrent Breas... Recurrent Cervi... Recurrent Colon... Recurrent Endom... Recurrent Esoph... Recurrent Esthe... Recurrent Extra... Recurrent Gallb... Recurrent Gastr... Recurrent Gastr... Recurrent Inver... Recurrent Lymph... Recurrent Lymph... Recurrent Metas... Recurrent Midli... Recurrent Mucoe... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Prost... Recurrent Recta... Recurrent Saliv... Recurrent Small... Recurrent Small... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Verru... Recurrent Verru... Small Intestine... Small Intestine... Small Intestine... Stage IV Adenoi... Stage IV Anal C... Stage IV Basal ... Stage IV Border... Stage IV Breast... Stage IV Colon ... Stage IV Endome... Stage IV Esopha... Stage IV Esthes... Stage IV Gastri... Stage IV Invert... Stage IV Lympho... Stage IV Lympho... Stage IV Midlin... Stage IV Mucoep... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Prosta... Stage IV Rectal... Stage IV Saliva... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Verruc... Stage IV Verruc... Stage IVA Cervi... Stage IVB Cervi... Triple-negative... Unresectable Ex... Unresectable Ga... Unspecified Adu... Untreated Metas...	7-hydroxystauro... irinotecan hydr... diagnostic labo...	18 Years -	National Cancer Institute (NCI)
Monoclonal Antibody Ch14.18, Sargramostim, Aldesleukin, and Isotretinoin After Autologous Stem Cell Transplant in Treating Patients With Neuroblastoma	NCT01041638	High Risk Neuro...	Aldesleukin Diagnostic Labo... Dinutuximab Isotretinoin Sargramostim	-	National Cancer Institute (NCI)
Genetic Test To Identify Previously Undetectable Minimal Residual Disease in Cell Samples From Younger Patients With Acute Lymphoblastic Leukemia	NCT01533168	Leukemia	cytogenetic ana... nucleic acid se... diagnostic labo... laboratory biom... medical chart r...	1 Year - 30 Years	Children's Oncology Group
Combination Chemotherapy and Interferon Alfa-2b in Treating Patients With Nonmetastatic Liver Cancer That Cannot Be Removed by Surgery	NCT00471484	Liver Cancer	recombinant int... doxorubicin hyd... fluorouracil oxaliplatin diagnostic labo... immunoenzyme te... immunohistochem... adjuvant therap... biopsy neoadjuvant the... therapeutic con...	16 Years - 75 Years	National Cancer Institute (NCI)
Genetic Testing in Predicting Biomarkers of Recurrence in Patients With Prostate Cancer Undergoing Surgery	NCT00977457	Prostate Cancer	DNA analysis DNA methylation... RNA analysis gene expression... polymerase chai... diagnostic labo... therapeutic con...	18 Years -	City of Hope Medical Center
HER-2 Mutations in Tumor Samples From Patients With Advanced Non-Small Cell Lung Cancer Treated on Clinical Trial ECOG-2598	NCT00896909	Lung Cancer	gene expression... mutation analys... polymerase chai... diagnostic labo...	18 Years - 120 Years	Eastern Cooperative Oncology Group
Genetic Analysis in Diagnosing Thyroid Cancer in Patients With Thyroid Nodules	NCT00316823	Head and Neck C...	gene expression... polymerase chai... reverse transcr... diagnostic labo... immunohistochem... needle biopsy	18 Years -	National Cancer Institute (NCI)
DNA Analysis of Tumor Tissue From Patients With Acute Myeloid Leukemia	NCT00897936	Leukemia	DNA methylation... comparative gen... fluorescence in... microarray anal... polymerase chai... diagnostic labo... immunologic tec...	18 Years - 120 Years	Eastern Cooperative Oncology Group
Temozolomide in Treating Patients With Recurrent Glioblastoma Multiforme or Other Malignant Glioma	NCT00498927	Brain and Centr...	temozolomide protein express... reverse transcr... diagnostic labo... immunoenzyme te...	18 Years - 120 Years	Memorial Sloan Kettering Cancer Center
Early Detection of Ovarian Cancer: GC/FT-ICR Mass Spectrometry and Canine Olfaction	NCT00757952	Ovarian Cancer	Fourier transfo... chromatography diagnostic labo... questionnaire a...	21 Years - 120 Years	Pine Street Foundation
Study of Tissue and Blood Samples From Patients With High-Grade Glioma	NCT01004887	Brain and Centr...	diagnostic labo...	18 Years -	Alliance for Clinical Trials in Oncology
Cyclophosphamide, Alvocidib, and Rituximab in Treating Patients With High Risk B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma	NCT01076556	Chronic Lymphoc... Prolymphocytic ... Recurrent Small... Refractory Chro... Stage I Chronic... Stage I Small L... Stage II Chroni... Stage II Small ... Stage III Chron... Stage III Small... Stage IV Chroni... Stage IV Small ...	Alvocidib Hydro... Cyclophosphamid... Diagnostic Labo... Pharmacological... Rituximab	18 Years -	National Cancer Institute (NCI)
Alvespimycin Hydrochloride in Treating Patients With Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-Cell Prolymphocytic Leukemia	NCT01126502	B-cell Chronic ... Prolymphocytic ... Recurrent Small... Refractory Chro...	alvespimycin hy... diagnostic labo... pharmacogenomic... pharmacological...	18 Years -	National Cancer Institute (NCI)
Biomarkers in Tissue Samples From Young Patients With Liver Cancer	NCT01336881	Childhood Hepat... Stage I Childho... Stage II Childh... Stage III Child... Stage IV Childh...	RNA analysis gene expression... microarray anal... nucleic acid se... diagnostic labo...	- 16 Years	Children's Oncology Group
Biomarkers in Predicting Response to Tamoxifen and Letrozole in Postmenopausal Women With Primary Breast Cancer Treated on Clinical Trial CAN-NCIC-MA17	NCT00897065	Breast Cancer	microarray anal... polymerase chai... protein express... diagnostic labo... fluorescent ant... immunohistochem... immunologic tec...	-	National Cancer Institute (NCI)
Studying Tumor Tissue Samples From Patients With Melanoma Who Have Undergone Sentinel Lymph Node Biopsy	NCT00897481	Melanoma (Skin)	gene expression... mutation analys... diagnostic labo... immunohistochem... sentinel lymph ...	-	National Cancer Institute (NCI)
S8814A Biomarkers in Predicting Outcome in Postmenopausal Women With Hormone Receptor-Positive, Node-Positive Breast Cancer Treated With Tamoxifen With or Without Cyclophosphamide, Doxorubicin, and Fluorouracil	NCT00897091	Breast Cancer	comparative gen... microarray anal... reverse transcr... diagnostic labo...	18 Years -	SWOG Cancer Research Network
Nivolumab for the Treatment of Patients With Metastatic Urothelial Cancer With ARID1A Mutation and Stratify Response Based on CXCL13 Expression	NCT04953104	Locally Advance... Locally Advance... Locally Advance... Locally Advance... Locally Advance... Metastatic Blad... Metastatic Rena... Metastatic Uret... Metastatic Uret... Metastatic Urot... Recurrent Bladd... Recurrent Renal... Recurrent Urete... Recurrent Ureth... Recurrent Uroth... Stage III Bladd... Stage III Renal... Stage III Urete... Stage III Ureth... Stage IIIA Blad... Stage IIIB Blad... Stage IV Bladde... Stage IV Renal ... Stage IV Ureter... Stage IV Urethr... Stage IVA Bladd... Stage IVB Bladd... Unresectable Bl... Unresectable Re... Unresectable Ur... Unresectable Ur... Unresectable Ur...	Diagnostic Labo... Nivolumab Relatlimab	18 Years -	M.D. Anderson Cancer Center
Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection	NCT01249443	HIV Infection Recurrent Anal ... Recurrent Breas... Recurrent Esoph... Recurrent Gastr... Recurrent Metas... Recurrent Non-s... Recurrent Ovari... Recurrent Saliv... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Verru... Recurrent Verru... Salivary Gland ... Stage IV Anal C... Stage IV Breast... Stage IV Esopha... Stage IV Gastri... Stage IV Non-sm... Stage IV Ovaria... Stage IV Saliva... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Verruc... Stage IV Verruc... Unspecified Adu...	vorinostat diagnostic labo... pharmacological... carboplatin paclitaxel	18 Years -	AIDS Malignancy Consortium
Monoclonal Antibody Ch14.18, Sargramostim, Aldesleukin, and Isotretinoin After Autologous Stem Cell Transplant in Treating Patients With Neuroblastoma	NCT01041638	High Risk Neuro...	Aldesleukin Diagnostic Labo... Dinutuximab Isotretinoin Sargramostim	-	National Cancer Institute (NCI)
Irinotecan, Cisplatin, Bevacizumab, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Esophageal Cancer	NCT00354679	Esophageal Canc...	bevacizumab cisplatin irinotecan hydr... proteomic profi... diagnostic labo... mass spectromet... adjuvant therap... neoadjuvant the... therapeutic con... radiation thera...	18 Years - 120 Years	Memorial Sloan Kettering Cancer Center
SARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood Cancer	NCT04977024	COVID-19 Infect... Hematopoietic a... Leukemia Lymphoma Plasma Cell Mye...	COVID-19 Vaccin... Diagnostic Labo... Synthetic MVA-b...	18 Years -	GeoVax, Inc.
7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)	NCT00031681	Advanced Adult ... Carcinoma of th... Estrogen Recept... Extensive Stage... Gastrointestina... HER2-negative B... Metastatic Gast... Ovarian Sarcoma Ovarian Stromal... Progesterone Re... Recurrent Adeno... Recurrent Adult... Recurrent Anal ... Recurrent Basal... Recurrent Borde... Recurrent Breas... Recurrent Cervi... Recurrent Colon... Recurrent Endom... Recurrent Esoph... Recurrent Esthe... Recurrent Extra... Recurrent Gallb... Recurrent Gastr... Recurrent Gastr... Recurrent Inver... Recurrent Lymph... Recurrent Lymph... Recurrent Metas... Recurrent Midli... Recurrent Mucoe... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Prost... Recurrent Recta... Recurrent Saliv... Recurrent Small... Recurrent Small... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Verru... Recurrent Verru... Small Intestine... Small Intestine... Small Intestine... Stage IV Adenoi... Stage IV Anal C... Stage IV Basal ... Stage IV Border... Stage IV Breast... Stage IV Colon ... Stage IV Endome... Stage IV Esopha... Stage IV Esthes... Stage IV Gastri... Stage IV Invert... Stage IV Lympho... Stage IV Lympho... Stage IV Midlin... Stage IV Mucoep... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Prosta... Stage IV Rectal... Stage IV Saliva... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Verruc... Stage IV Verruc... Stage IVA Cervi... Stage IVB Cervi... Triple-negative... Unresectable Ex... Unresectable Ga... Unspecified Adu... Untreated Metas...	7-hydroxystauro... irinotecan hydr... diagnostic labo...	18 Years -	National Cancer Institute (NCI)
Enzastaurin and Bevacizumab in Treating Patients With Locally Advanced or Metastatic Cancer	NCT00550927	Unspecified Adu...	bevacizumab enzastaurin hyd... diagnostic labo... pharmacological...	18 Years -	Eli Lilly and Company
CA 125 Levels in Treating Patients With Relapsed Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Who Are Receiving Tamoxifen	NCT00305838	Fallopian Tube ... Ovarian Cancer Primary Periton...	tamoxifen citra... diagnostic labo...	-	National Cancer Institute (NCI)
Study of Tumor Tissue Testing in Selecting Treatment for Patients With Metastatic or Locally Advanced Colorectal Cancer	NCT00975897	Colorectal Canc...	bevacizumab cetuximab fluorouracil irinotecan hydr... leucovorin calc... oxaliplatin RNA analysis cytogenetic ana... fluorescence in... gene expression... mutation analys... protein express... diagnostic labo... immunohistochem... questionnaire a... cognitive asses...	18 Years -	National Cancer Institute (NCI)
MK2206 in Treating Patients With Advanced Refractory Biliary Cancer That Cannot Be Removed by Surgery	NCT01425879	Advanced Adult ... Localized Non-R... Recurrent Adult... Recurrent Gallb... Stage IV Distal... Stage IV Gallbl... Unresectable Ex... Unresectable Ga...	Akt Inhibitor M... Diagnostic Labo... Pharmacological...	18 Years -	National Cancer Institute (NCI)
CA 125 Levels in Treating Patients With Relapsed Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Who Are Receiving Tamoxifen	NCT00305838	Fallopian Tube ... Ovarian Cancer Primary Periton...	tamoxifen citra... diagnostic labo...	-	National Cancer Institute (NCI)
Biomarkers in Blood and Tissue Samples From Patients With Uterine Cancer	NCT01344837	Endometrial Ser... Stage I Uterine... Stage II Uterin... Stage III Uteri... Stage IV Uterin...	Diagnostic Labo... Immunohistochem... Medical Chart R... Microarray Anal... Study of Socioe... Western Blottin...	-	GOG Foundation
Study to Predict Risk of Relapse in Bone Marrow Cell Samples From Younger Patients With Acute Myeloid Leukemia	NCT01438138	Leukemia	diagnostic labo...	- 21 Years	Children's Oncology Group
Study to Predict Risk of Relapse in Bone Marrow Cell Samples From Younger Patients With Acute Myeloid Leukemia	NCT01438138	Leukemia	diagnostic labo...	- 21 Years	Children's Oncology Group
Lapatinib in Treating Patients With Advanced or Metastatic Breast Cancer That Overexpresses HER2	NCT00544804	Breast Cancer Metastatic Canc...	lapatinib ditos... gene expression... diagnostic labo...	18 Years -	University of California, San Francisco
Enzastaurin and Bevacizumab in Treating Patients With Locally Advanced or Metastatic Cancer	NCT00550927	Unspecified Adu...	bevacizumab enzastaurin hyd... diagnostic labo... pharmacological...	18 Years -	Eli Lilly and Company
Biomarkers in Tissue Samples From Young Patients With Liver Cancer	NCT01336881	Childhood Hepat... Stage I Childho... Stage II Childh... Stage III Child... Stage IV Childh...	RNA analysis gene expression... microarray anal... nucleic acid se... diagnostic labo...	- 16 Years	Children's Oncology Group
Genetic Analysis in Diagnosing Thyroid Cancer in Patients With Thyroid Nodules	NCT00316823	Head and Neck C...	gene expression... polymerase chai... reverse transcr... diagnostic labo... immunohistochem... needle biopsy	18 Years -	National Cancer Institute (NCI)
Nivolumab for the Treatment of Patients With Metastatic Urothelial Cancer With ARID1A Mutation and Stratify Response Based on CXCL13 Expression	NCT04953104	Locally Advance... Locally Advance... Locally Advance... Locally Advance... Locally Advance... Metastatic Blad... Metastatic Rena... Metastatic Uret... Metastatic Uret... Metastatic Urot... Recurrent Bladd... Recurrent Renal... Recurrent Urete... Recurrent Ureth... Recurrent Uroth... Stage III Bladd... Stage III Renal... Stage III Urete... Stage III Ureth... Stage IIIA Blad... Stage IIIB Blad... Stage IV Bladde... Stage IV Renal ... Stage IV Ureter... Stage IV Urethr... Stage IVA Bladd... Stage IVB Bladd... Unresectable Bl... Unresectable Re... Unresectable Ur... Unresectable Ur... Unresectable Ur...	Diagnostic Labo... Nivolumab Relatlimab	18 Years -	M.D. Anderson Cancer Center
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic Leukemia	NCT00866918	Childhood Acute... Myeloid Neoplas...	Arsenic Trioxid... Cytarabine Diagnostic Labo... Idarubicin Mercaptopurine Methotrexate Mitoxantrone Hy... Tretinoin	2 Years - 21 Years	Children's Oncology Group
EF5 to Evaluate Tumor Hypoxia in Patients With High-Grade Soft Tissue Sarcoma or Mouth Cancer	NCT00896961	Stage I Adult S... Stage I Squamou... Stage II Adult ... Stage II Squamo... Stage III Adult... Stage III Squam...	EF5 diagnostic labo... pharmacological...	18 Years -	National Cancer Institute (NCI)
Studying Biomarkers in Samples From Younger Patients With Wilms Tumor	NCT01576198	Kidney Cancer	DNA analysis nucleic acid am... diagnostic labo... medical chart r...	- 120 Years	Children's Oncology Group
Bevacizumab and Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer	NCT00544011	Colorectal Canc...	bevacizumab capecitabine fluorouracil irinotecan hydr... diagnostic labo...	18 Years - 80 Years	National Cancer Institute (NCI)
Fludeoxyglucose F 18 PET Imaging in Determining Protein and Gene Expression Signatures in Patients With Premalignant Polyps or Colon Cancer	NCT00550628	Colorectal Canc... Neoplasm of Unc...	DNA methylation... fluorescence in... gene expression... polymerase chai... protein express... reverse transcr... diagnostic labo... immunoenzyme te... immunohistochem... biopsy therapeutic con... fludeoxyglucose...	15 Years -	Memorial Sloan Kettering Cancer Center
EF5 to Evaluate Tumor Hypoxia in Patients With High-Grade Soft Tissue Sarcoma or Mouth Cancer	NCT00896961	Stage I Adult S... Stage I Squamou... Stage II Adult ... Stage II Squamo... Stage III Adult... Stage III Squam...	EF5 diagnostic labo... pharmacological...	18 Years -	National Cancer Institute (NCI)
Genetics Study of Tissue Collected From Patients With Acute Myeloid Leukemia	NCT00898092	Leukemia	microarray anal... molecular genet... mutation analys... polymerase chai... reverse transcr... diagnostic labo...	15 Years - 59 Years	Alliance for Clinical Trials in Oncology
Bicalutamide in Treating Patients With Metastatic Breast Cancer	NCT00468715	Breast Cancer	bicalutamide diagnostic labo... immunohistochem...	18 Years - 120 Years	Memorial Sloan Kettering Cancer Center
Nipple Secretion Samples in Detecting Breast Cancer in Patients and Healthy Participants Undergoing Breast Cancer Screening, Breast Diagnostic Studies, or Treatment for Benign Breast Disease	NCT00813878	Breast Cancer	protein analysi... protein express... proteomic profi... diagnostic labo... immunohistochem... liquid chromato... mass spectromet... fine-needle asp... needle biopsy radiomammograph...	18 Years - 120 Years	City of Hope Medical Center

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: